Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2023-10-16 Sale |
2023-10-18 6:21 pm |
CymaBay Therapeutics Inc. | CBAY | Quinlan Paul T General Counsel |
5,000 | $13.76 | $68,798 | 122,000 (Direct) |
View |
| 2023-10-09 Sale |
2023-10-10 5:04 pm |
CymaBay Therapeutics Inc. | CBAY | Shah Sujal Chief Executive Officer |
64,861 | $14.2 | $921,286 | 301,029 (Direct) |
View |
| 2023-09-29 Sale |
2023-09-29 5:54 pm |
CymaBay Therapeutics Inc. | CBAY | EMSTER KURT VON Director |
15,921 | $15.68 | $249,675 | 108,406 (Indirect Direct) |
View |
| 2023-09-18 Sale |
2023-09-19 5:27 pm |
CymaBay Therapeutics Inc. | CBAY | McWherter Charles President of R&D |
21,746 | $16.22 | $352,733 | 59,417 (Direct) |
View |
| 2023-09-15 Sale |
2023-09-19 5:23 pm |
CymaBay Therapeutics Inc. | CBAY | Quinlan Paul T General Counsel |
53,000 | $16.87 | $894,141 | 127,000 (Direct) |
View |
| 2023-08-18 Sale |
2023-08-18 7:03 pm |
CymaBay Therapeutics Inc. | CBAY | McWherter Charles President of R&D |
21,746 | $11.47 | $249,359 | 81,163 (Direct) |
View |
| 2023-08-15 Sale |
2023-08-16 4:57 pm |
CymaBay Therapeutics Inc. | CBAY | Quinlan Paul T General Counsel |
5,000 | $11.91 | $59,551 | 180,000 (Direct) |
View |
| 2023-08-09 Sale |
2023-08-11 6:26 pm |
CymaBay Therapeutics Inc. | CBAY | Menold Daniel Vice President, Finance |
20,945 | $12.35 | $258,744 | 0 (Direct) |
View |
| 2023-07-18 Sale |
2023-07-19 6:05 pm |
CymaBay Therapeutics Inc. | CBAY | McWherter Charles President of R&D |
21,749 | $11.43 | $248,519 | 102,909 (Direct) |
View |
| 2023-07-14 Sale |
2023-07-14 6:52 pm |
CymaBay Therapeutics Inc. | CBAY | Quinlan Paul T General Counsel |
5,000 | $11.81 | $59,050 | 185,000 (Direct) |
View |
| 2023-06-30 Sale |
2023-06-30 4:51 pm |
CymaBay Therapeutics Inc. | CBAY | Quinlan Paul T General Counsel |
5,000 | $10.05 | $50,250 | 190,000 (Direct) |
View |
| 2023-06-20 Sale |
2023-06-21 6:46 pm |
CymaBay Therapeutics Inc. | CBAY | McWherter Charles President of R&D |
21,749 | $8.1559 | $177,383 | 124,658 (Direct) |
View |
| 2023-05-18 Sale |
2023-05-19 6:00 pm |
CymaBay Therapeutics Inc. | CBAY | McWherter Charles President of R&D |
21,749 | $9.0757 | $197,387 | 146,407 (Direct) |
View |
| 2023-05-15 Sale |
2023-05-17 7:11 pm |
CymaBay Therapeutics Inc. | CBAY | Quinlan Paul T General Counsel |
5,000 | $10.37 | $51,831 | 195,000 (Direct) |
View |
| 2023-04-13 Sale |
2023-04-17 7:24 pm |
CymaBay Therapeutics Inc. | CBAY | KIM DENNIS D Chief Medical Officer |
120,000 | $9.5035 | $1,140,416 | 472,019 (Direct) |
View |
| 2023-03-28 Sale |
2023-03-30 5:39 pm |
CymaBay Therapeutics Inc. | CBAY | KIM DENNIS D Chief Medical Officer |
100 | $8.985 | $899 | 309,900 (Direct) |
View |
| 2022-06-06 Purchase |
2022-06-07 08:14 am |
CymaBay Therapeutics Inc. | CBAY | Shah Sujal Chief Executive Officer |
51,301 | $1.95 | $100,037 | 171,301 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2023-10-16 Exercise |
2023-10-18 6:22 pm |
N/A N/A |
CymaBay Therapeutics Inc. | CBAY | Menold Daniel Vice President, Finance |
17,500 | $3.45 | 17,500 (Direct) |
View |
| 2023-10-16 Exercise |
2023-10-18 6:22 pm |
N/A 2027-05-02 |
CymaBay Therapeutics Inc. | CBAY | Menold Daniel Vice President, Finance |
17,500 | $0 | 17,500 (Direct) |
View |
| 2023-10-16 Exercise |
2023-10-18 6:21 pm |
N/A N/A |
CymaBay Therapeutics Inc. | CBAY | Quinlan Paul T General Counsel |
5,000 | $2.94 | 122,000 (Direct) |
View |
| 2023-10-16 Exercise |
2023-10-18 6:21 pm |
N/A 2032-01-24 |
CymaBay Therapeutics Inc. | CBAY | Quinlan Paul T General Counsel |
5,000 | $0 | 122,000 (Direct) |
View |
| 2023-10-09 Exercise |
2023-10-10 5:04 pm |
N/A N/A |
CymaBay Therapeutics Inc. | CBAY | Shah Sujal Chief Executive Officer |
64,861 | $5 | 301,029 (Direct) |
View |
| 2023-10-09 Exercise |
2023-10-10 5:04 pm |
N/A 2023-12-22 |
CymaBay Therapeutics Inc. | CBAY | Shah Sujal Chief Executive Officer |
64,861 | $0 | 301,029 (Direct) |
View |
| 2023-09-29 Exercise |
2023-09-29 5:54 pm |
N/A N/A |
CymaBay Therapeutics Inc. | CBAY | EMSTER KURT VON Director |
15,921 | $5 | 108,406 (Direct) |
View |
| 2023-09-29 Exercise |
2023-09-29 5:54 pm |
N/A 2023-10-30 |
CymaBay Therapeutics Inc. | CBAY | EMSTER KURT VON Director |
15,921 | $0 | 108,406 (Direct) |
View |
| 2023-09-18 Exercise |
2023-09-19 5:27 pm |
N/A N/A |
CymaBay Therapeutics Inc. | CBAY | McWherter Charles President of R&D |
21,746 | $5 | 59,417 (Direct) |
View |
| 2023-09-18 Exercise |
2023-09-19 5:27 pm |
N/A 2023-10-30 |
CymaBay Therapeutics Inc. | CBAY | McWherter Charles President of R&D |
21,746 | $0 | 59,417 (Direct) |
View |
| 2023-09-15 Exercise |
2023-09-19 5:25 pm |
N/A N/A |
CymaBay Therapeutics Inc. | CBAY | Menold Daniel Vice President, Finance |
1,545 | $1.82 | 0 (Direct) |
View |
| 2023-09-15 Exercise |
2023-09-19 5:25 pm |
N/A 2026-07-24 |
CymaBay Therapeutics Inc. | CBAY | Menold Daniel Vice President, Finance |
16,545 | $0 | 0 (Direct) |
View |
| 2023-09-15 Exercise |
2023-09-19 5:25 pm |
N/A N/A |
CymaBay Therapeutics Inc. | CBAY | Menold Daniel Vice President, Finance |
15,000 | $1.72 | 0 (Direct) |
View |
| 2023-09-15 Exercise |
2023-09-19 5:23 pm |
N/A N/A |
CymaBay Therapeutics Inc. | CBAY | Quinlan Paul T General Counsel |
29,000 | $2.94 | 127,000 (Direct) |
View |
| 2023-09-15 Exercise |
2023-09-19 5:23 pm |
N/A 2032-01-24 |
CymaBay Therapeutics Inc. | CBAY | Quinlan Paul T General Counsel |
53,000 | $0 | 127,000 (Direct) |
View |
| 2023-08-18 Exercise |
2023-08-18 7:03 pm |
N/A N/A |
CymaBay Therapeutics Inc. | CBAY | McWherter Charles President of R&D |
21,746 | $5 | 81,163 (Direct) |
View |
| 2023-08-18 Exercise |
2023-08-18 7:03 pm |
N/A 2023-10-30 |
CymaBay Therapeutics Inc. | CBAY | McWherter Charles President of R&D |
21,746 | $0 | 81,163 (Direct) |
View |
| 2023-08-15 Exercise |
2023-08-16 4:59 pm |
N/A N/A |
CymaBay Therapeutics Inc. | CBAY | Menold Daniel Vice President, Finance |
7,000 | $10 | 0 (Direct) |
View |
| 2023-08-15 Exercise |
2023-08-16 4:59 pm |
N/A N/A |
CymaBay Therapeutics Inc. | CBAY | Menold Daniel Vice President, Finance |
8,500 | $1.06 | 0 (Direct) |
View |
| 2023-08-15 Exercise |
2023-08-16 4:59 pm |
N/A 2026-01-25 |
CymaBay Therapeutics Inc. | CBAY | Menold Daniel Vice President, Finance |
15,500 | $0 | 0 (Direct) |
View |
| 2023-08-15 Exercise |
2023-08-16 4:57 pm |
N/A N/A |
CymaBay Therapeutics Inc. | CBAY | Quinlan Paul T General Counsel |
5,000 | $2.94 | 180,000 (Direct) |
View |
| 2023-08-15 Exercise |
2023-08-16 4:57 pm |
N/A 2032-01-24 |
CymaBay Therapeutics Inc. | CBAY | Quinlan Paul T General Counsel |
5,000 | $0 | 180,000 (Direct) |
View |
| 2023-08-09 Exercise |
2023-08-11 6:26 pm |
N/A N/A |
CymaBay Therapeutics Inc. | CBAY | Menold Daniel Vice President, Finance |
20,945 | $5 | 0 (Direct) |
View |
| 2023-08-09 Exercise |
2023-08-11 6:26 pm |
N/A 2024-01-21 |
CymaBay Therapeutics Inc. | CBAY | Menold Daniel Vice President, Finance |
20,945 | $0 | 0 (Direct) |
View |
| 2023-07-18 Exercise |
2023-07-19 6:05 pm |
N/A N/A |
CymaBay Therapeutics Inc. | CBAY | McWherter Charles President of R&D |
21,749 | $5 | 102,909 (Direct) |
View |
| 2023-07-18 Exercise |
2023-07-19 6:05 pm |
N/A 2023-10-30 |
CymaBay Therapeutics Inc. | CBAY | McWherter Charles President of R&D |
21,749 | $0 | 102,909 (Direct) |
View |
| 2023-07-14 Exercise |
2023-07-14 6:52 pm |
N/A N/A |
CymaBay Therapeutics Inc. | CBAY | Quinlan Paul T General Counsel |
5,000 | $2.94 | 185,000 (Direct) |
View |
| 2023-07-14 Exercise |
2023-07-14 6:52 pm |
N/A 2032-01-24 |
CymaBay Therapeutics Inc. | CBAY | Quinlan Paul T General Counsel |
5,000 | $0 | 185,000 (Direct) |
View |
| 2023-06-30 Exercise |
2023-06-30 4:51 pm |
N/A N/A |
CymaBay Therapeutics Inc. | CBAY | Quinlan Paul T General Counsel |
5,000 | $2.94 | 190,000 (Direct) |
View |
| 2023-06-30 Exercise |
2023-06-30 4:51 pm |
N/A 2032-01-24 |
CymaBay Therapeutics Inc. | CBAY | Quinlan Paul T General Counsel |
5,000 | $0 | 190,000 (Direct) |
View |
| 2023-06-20 Exercise |
2023-06-21 6:46 pm |
N/A N/A |
CymaBay Therapeutics Inc. | CBAY | McWherter Charles President of R&D |
21,749 | $5 | 124,658 (Direct) |
View |
| 2023-06-20 Exercise |
2023-06-21 6:46 pm |
N/A 2023-10-30 |
CymaBay Therapeutics Inc. | CBAY | McWherter Charles President of R&D |
21,749 | $0 | 124,658 (Direct) |
View |
| 2023-05-22 Option Award |
2023-05-22 5:13 pm |
N/A 2033-05-21 |
CymaBay Therapeutics Inc. | CBAY | Shantharam Harish Chief Financial Officer |
360,000 | $0 | 360,000 (Direct) |
View |
| 2023-05-18 Exercise |
2023-05-19 6:00 pm |
N/A N/A |
CymaBay Therapeutics Inc. | CBAY | McWherter Charles President of R&D |
21,749 | $5 | 146,407 (Direct) |
View |
| 2023-05-18 Exercise |
2023-05-19 6:00 pm |
N/A 2023-10-30 |
CymaBay Therapeutics Inc. | CBAY | McWherter Charles President of R&D |
21,749 | $0 | 146,407 (Direct) |
View |
| 2023-05-15 Exercise |
2023-05-17 7:11 pm |
N/A N/A |
CymaBay Therapeutics Inc. | CBAY | Quinlan Paul T General Counsel |
5,000 | $2.94 | 195,000 (Direct) |
View |
| 2023-05-15 Exercise |
2023-05-17 7:11 pm |
N/A 2032-01-24 |
CymaBay Therapeutics Inc. | CBAY | Quinlan Paul T General Counsel |
5,000 | $0 | 195,000 (Direct) |
View |
| 2023-04-13 Exercise |
2023-04-17 7:24 pm |
N/A N/A |
CymaBay Therapeutics Inc. | CBAY | KIM DENNIS D Chief Medical Officer |
120,000 | $4.37 | 472,019 (Direct) |
View |
| 2023-04-13 Exercise |
2023-04-17 7:24 pm |
N/A 2031-05-16 |
CymaBay Therapeutics Inc. | CBAY | KIM DENNIS D Chief Medical Officer |
120,000 | $0 | 472,019 (Direct) |
View |
| 2023-03-28 Exercise |
2023-03-30 5:39 pm |
N/A N/A |
CymaBay Therapeutics Inc. | CBAY | KIM DENNIS D Chief Medical Officer |
100 | $4.37 | 309,900 (Direct) |
View |
| 2023-03-28 Exercise |
2023-03-30 5:39 pm |
N/A 2031-05-16 |
CymaBay Therapeutics Inc. | CBAY | KIM DENNIS D Chief Medical Officer |
100 | $0 | 309,900 (Direct) |
View |
| 2023-01-25 Option Award |
2023-01-27 4:35 pm |
N/A 2033-01-24 |
CymaBay Therapeutics Inc. | CBAY | Dorling Janet Director |
25,000 | $0 | 25,000 (Direct) |
View |
| 2023-01-25 Option Award |
2023-01-27 4:34 pm |
N/A 2033-01-24 |
CymaBay Therapeutics Inc. | CBAY | EMSTER KURT VON Director |
25,000 | $0 | 25,000 (Direct) |
View |
| 2023-01-25 Option Award |
2023-01-27 4:34 pm |
N/A 2033-01-24 |
CymaBay Therapeutics Inc. | CBAY | WIGGANS THOMAS G Director |
25,000 | $0 | 25,000 (Direct) |
View |
| 2023-01-25 Option Award |
2023-01-27 4:34 pm |
N/A 2033-01-24 |
CymaBay Therapeutics Inc. | CBAY | Loewy Caroline M Director |
25,000 | $0 | 25,000 (Direct) |
View |
| 2023-01-25 Option Award |
2023-01-27 4:33 pm |
N/A 2033-01-24 |
CymaBay Therapeutics Inc. | CBAY | Wills Robert James Director |
25,000 | $0 | 25,000 (Direct) |
View |
| 2023-01-25 Option Award |
2023-01-27 4:33 pm |
N/A 2033-01-24 |
CymaBay Therapeutics Inc. | CBAY | Lefebvre Eric Director |
25,000 | $0 | 25,000 (Direct) |
View |
| 2023-01-25 Option Award |
2023-01-27 4:30 pm |
N/A 2033-01-24 |
CymaBay Therapeutics Inc. | CBAY | KIM DENNIS D Chief Medical Officer |
180,000 | $0 | 180,000 (Direct) |
View |
| 2023-01-25 Option Award |
2023-01-27 4:27 pm |
N/A 2033-01-24 |
CymaBay Therapeutics Inc. | CBAY | Shah Sujal Chief Executive Officer |
800,000 | $0 | 800,000 (Direct) |
View |
| 2023-01-25 Option Award |
2023-01-27 4:27 pm |
N/A 2033-01-24 |
CymaBay Therapeutics Inc. | CBAY | McWherter Charles President of R&D |
300,000 | $0 | 300,000 (Direct) |
View |
| 2023-01-25 Option Award |
2023-01-27 4:27 pm |
N/A 2033-01-24 |
CymaBay Therapeutics Inc. | CBAY | Dickinson Klara Chief Regulatory Officer |
215,000 | $0 | 215,000 (Direct) |
View |
| 2023-01-25 Option Award |
2023-01-27 4:26 pm |
N/A 2033-01-24 |
CymaBay Therapeutics Inc. | CBAY | STUART LEWIS J Chief Commercial Officer |
215,000 | $0 | 215,000 (Direct) |
View |
| 2023-01-25 Option Award |
2023-01-27 4:25 pm |
N/A 2033-01-24 |
CymaBay Therapeutics Inc. | CBAY | Menold Daniel Vice President, Finance |
100,000 | $0 | 100,000 (Direct) |
View |
| 2023-01-25 Option Award |
2023-01-27 4:23 pm |
N/A 2033-01-24 |
CymaBay Therapeutics Inc. | CBAY | Quinlan Paul T General Counsel |
215,000 | $0 | 215,000 (Direct) |
View |
| 2022-03-21 Option Award |
2022-03-21 5:40 pm |
N/A 2032-03-20 |
CymaBay Therapeutics Inc. | CBAY | Lefebvre Eric Director |
115,000 | $0 | 115,000 (Direct) |
View |
| 2022-01-25 Option Award |
2022-01-27 4:59 pm |
N/A 2032-01-24 |
CymaBay Therapeutics Inc. | CBAY | Quinlan Paul T General Counsel |
200,000 | $0 | 200,000 (Direct) |
View |